
{
  "Company Overview": {
    "Name": "Cellecor Gadgets Ltd",
    "Sector": "Retail",
    "Industry": "Trading",
    "Business Description": "Cellecor Gadgets Ltd is in the business of selling consumer electronic products. It sells products in its own brand, including mobile feature phones, smartwatches, TWS (True Wireless Stereo) earbuds, neckbands, LED TVs, etc. which it outsources from various electronic assemblers and manufacturers.",
    "Market Position": "Information not explicitly provided in the HTML."
  },
  "Financial Metrics": {
    "Market Cap": "₹ 1,349 Cr.",
    "Current Price": "₹ 62.0",
    "High/Low": "₹ 71.8 / ₹ 15.0",
    "P/E Ratio": "56.9",
    "Book Value": "₹ 4.99",
    "Dividend Yield": "0.00%",
    "ROCE": "29.2%",
    "ROE": "31.0%",
    "Face Value": "₹ 1.00",
    "Debt-to-Equity Ratio": "Information not explicitly provided in the HTML." 
  },
  "Performance Trends": {
    "Quarterly Results": {
      "Sep 2022": {
        "Sales": "114 Cr.",
        "Expenses": "109 Cr.",
        "Operating Profit": "5 Cr.",
        "OPM %": "4%",
        "Net Profit": "3 Cr.",
        "EPS": "30.64"
      },
      "Mar 2023": {
        "Sales": "151 Cr.",
        "Expenses": "143 Cr.",
        "Operating Profit": "8 Cr.",
        "OPM %": "5%",
        "Net Profit": "5 Cr.",
        "EPS": "42.73"
      },
      "Sep 2023": {
        "Sales": "210 Cr.",
        "Expenses": "197 Cr.",
        "Operating Profit": "13 Cr.",
        "OPM %": "6%",
        "Net Profit": "7 Cr.",
        "EPS": "0.33"
      },
      "Mar 2024": {
        "Sales": "291 Cr.",
        "Expenses": "274 Cr.",
        "Operating Profit": "17 Cr.",
        "OPM %": "6%",
        "Net Profit": "9 Cr.",
        "EPS": "0.43"
      },
      "Sep 2024": {
        "Sales": "426 Cr.",
        "Expenses": "400 Cr.",
        "Operating Profit": "25 Cr.",
        "OPM %": "6%",
        "Net Profit": "15 Cr.",
        "EPS": "0.70"
      }
    },
    "Annual Results": {
      "Mar 2021": {
        "Sales": "0 Cr.",
        "Expenses": "0 Cr.",
        "Net Profit": "-0 Cr.",
        "EPS": "-0.20"
      },
      "Mar 2022": {
        "Sales": "121 Cr.",
        "Expenses": "118 Cr.",
        "Net Profit": "2 Cr.",
        "EPS": "21.40"
      },
      "Mar 2023": {
        "Sales": "264 Cr.",
        "Expenses": "252 Cr.",
        "Net Profit": "8 Cr.",
        "EPS": "73.36"
      },
      "Mar 2024": {
        "Sales": "500 Cr.",
        "Expenses": "471 Cr.",
        "Net Profit": "16 Cr.",
        "EPS": "0.77"
      },
      "TTM": {
        "Sales": "717 Cr.",
        "Expenses": "674 Cr.",
        "Net Profit": "24 Cr.",
        "EPS": "1.13"
      }
    },
    "Balance Sheet Highlights": {
      "Mar 2021": {
        "Equity Capital": "0.10 Cr.",
        "Reserves": "-0 Cr.",
        "Borrowings": "0 Cr.",
        "Other Liabilities": "0 Cr.",
        "Total Liabilities": "0 Cr.",
        "Fixed Assets": "0 Cr.",
        "Other Assets": "0 Cr.",
        "Total Assets": "0 Cr."
      },
      "Mar 2024": {
        "Equity Capital": "21 Cr.",
        "Reserves": "69 Cr.",
        "Borrowings": "75 Cr.",
        "Other Liabilities": "21 Cr.",
        "Total Liabilities": "186 Cr.",
        "Fixed Assets": "1 Cr.",
        "Other Assets": "185 Cr.",
        "Total Assets": "186 Cr."
      },
      "Sep 2024": {
        "Equity Capital": "21 Cr.",
        "Reserves": "84 Cr.",
        "Borrowings": "76 Cr.",
        "Other Liabilities": "27 Cr.",
        "Total Liabilities": "208 Cr.",
        "Fixed Assets": "18 Cr.",
        "Other Assets": "189 Cr.",
        "Total Assets": "208 Cr."
      }
    },
    "Cash Flow Summaries": {
      "Mar 2021": {
        "Cash from Operating Activity": "0 Cr.",
        "Cash from Investing Activity": "0 Cr.",
        "Cash from Financing Activity": "0 Cr.",
        "Net Cash Flow": "0 Cr."
      },
      "Mar 2024": {
        "Cash from Operating Activity": "-102 Cr.",
        "Cash from Investing Activity": "-1 Cr.",
        "Cash from Financing Activity": "107 Cr.",
        "Net Cash Flow": "4 Cr."
      }
    }
  },
  "Ratios": {
    "Growth Ratios": {
      "Compounded Sales Growth (3 Years)": "%",
      "Compounded Profit Growth (3 Years)": "831%",
      "Stock Price CAGR (1 Year)": "134%"
    },
    "Liquidity Ratios": {
      "Information not explicitly provided in the HTML."
    },
    "Profitability Ratios": {
      "ROCE (Mar 2024)": "29%"
    },
    "Valuation Ratios": {
      "P/E Ratio": "56.9",
      "Price to Book": "Information not explicitly provided but implied by the cons section."
    },
    "Other Ratios": {
      "Debtor Days (Mar 2024)": "14",
      "Inventory Days (Mar 2024)": "74",
      "Days Payable (Mar 2024)": "12",
      "Cash Conversion Cycle (Mar 2024)": "76",
      "Working Capital Days (Mar 2024)": "115"
    }
  },
  "Peer Comparison": {
    "Peers": [
      {"Name": "Trent", "CMP": "6831.55", "P/E": "178.61", "Mar Cap": "242853.04 Cr.", "Div Yld": "0.05%", "ROCE": "23.79%"},
      {"Name": "Avenue Super.", "CMP": "3408.30", "P/E": "82.55", "Mar Cap": "221789.35 Cr.", "Div Yld": "0.00%", "ROCE": "19.41%"},
      {"Name": "Brainbees Solut.", "CMP": "638.75", "P/E": "33162.89", "Mar Cap": "0.00 Cr.", "Div Yld": "0.00%", "ROCE": "-4.00%"},
      {"Name": "Redtape", "CMP": "855.85", "P/E": "75.10", "Mar Cap": "11828.01 Cr.", "Div Yld": "0.00%", "ROCE": "29.27%"},
      {"Name": "Medplus Health", "CMP": "848.05", "P/E": "101.23", "Mar Cap": "10138.20 Cr.", "Div Yld": "0.00%", "ROCE": "6.66%"},
      {"Name": "Ethos Ltd", "CMP": "3101.45", "P/E": "83.80", "Mar Cap": "7592.49 Cr.", "Div Yld": "0.00%", "ROCE": "14.91%"},
      {"Name": "V-Mart Retail", "CMP": "3780.30", "P/E": "7483.87", "Mar Cap": "0.00 Cr.", "Div Yld": "0.00%", "ROCE": "0.54%"}
    ],
    "Median": {
      "P/E": "56.92",
      "Mar Cap": "1343.11 Cr.",
      "Div Yld": "0.0%",
      "ROCE": "13.52%"
    }
  },
  "Other Insights": {
    "Pros": [
      "Company has a good return on equity (ROE) track record: 3 Years ROE 43.1%",
    ],
    "Cons": [
      "Stock is trading at 12.4 times its book value",
      "Though the company is reporting repeated profits, it is not paying out dividend",
      "Promoter holding has decreased over last quarter: -1.90%",
      "Working capital days have increased from 56.4 days to 115 days"
    ],
    "Disclaimer": "The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.",
    "Shareholding Pattern Notes": "* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards. Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes."
  }
}
